D-1010-2019 Class III Terminated

Recalled by Lupin Pharmaceuticals Inc. — Baltimore, MD

FDA drug recall D-1010-2019 was initiated by Lupin Pharmaceuticals Inc. on Mar 13, 2019 and is designated Class III. Reason for recall: Defective Container: Repetitive complaints received indicating pump not working. The recall status is terminated (terminated Jun 26, 2020). Affected quantity: 3,200 bottles.

Recall details

Product Type
Drugs
Report Date
Mar 27, 2019
Initiation Date
Mar 13, 2019
Termination Date
Jun 26, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
3,200 bottles

Product description

Testosterone Topical Solution, 30mg/1.5mL, 110mL bottles, Rx only, Manufactured for: Lupin Pharmaceuticals Inc. Baltimore, Maryland 21202 United States, Manufactured by: Lupin Limited Pithampur (M.P.) 454 775 INDIA, NDC 68180-943-11

Reason for recall

Defective Container: Repetitive complaints received indicating pump not working.

Distribution pattern

Recalled product was distributed to 7 major wholesale/drug chain distributors and 1 supermarket chain that may have further distribute the product throughout the United States.

Code information

Lot # K700086, Exp 11/2019

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1010-2019
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1010-2019. Report a data issue: hello@regdatalab.com.